Who backs Delfi Diagnostics?
27 investors| Investor | Type |
|---|---|
| Menlo Ventures | Venture capital |
| OrbiMed | Growth equity |
| Mirae Asset Capital | Venture capital |
| Point72 Ventures | Venture capital |
| T. Rowe Price Group | — |
| Blue Owl Capital | — |
| Osage University Partners | Venture capital |
| Foresite Capital | Venture capital |
| Samsara BioCapital | Venture capital |
| DFJ Growth | Venture capital |
| + 17 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Delfi Diagnostics investors
27 investors are on record for Delfi Diagnostics, including Menlo Ventures, OrbiMed, Mirae Asset Capital and Point72 Ventures. By type, the record holds 10 venture capital firms, 1 family office and 1 hedge fund. The debt round in Dec 2025 drew 50 investors.
Free account
More of Delfi Diagnostics with a free account
- ·The complete investor list: 27 names
- ·Watch Delfi Diagnostics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 27 firms already write checks for companies like Delfi Diagnostics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View